AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 NOV 27 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Results from RNA interference studies indicated that blocking the expression of two cysteine protease genes in the malaria parasite Plasmodium falciparum causes abnormalities in and inhibits growth of the organism.
"Malaria remains a public health problem of enormous magnitude, affecting over 500 million people every year," said Pawan Malhotra and colleagues at the International Centre for Genetic Engineering and Biotechnology in New Delhi. "Lack of success in the past in the development of new drug/vaccines has mainly been attributed to poor understanding of the functions of different parasite proteins. Recently, RNA interference (RNAi) has emerged as a simple and incisive technique to study gene functions in a variety of organisms."
Introduction of double-stranded RNA (dsRNA) into an organism can silence related gene expression. Called RNA interference (RNAi), this phenomenon can be exploited to study the morphological effects caused by specific genes (Double-stranded RNA-mediated gene silencing of cysteine proteases (falcipain-1 and -2) of Plasmodium falciparum. Molecular Microbiology, 2002;45(5):1245-1254).
Malhotra and associates employed RNAi to study the effects of silencing the falcipain-1 and -2 cysteine protease genes of P. falciparum and found results similar to those induced by treatment with the cysteine protease inhibitor E-64: parasite growth was obstructed and the parasite developed severe morphological defects and accumulated ...